MDxHealth Notice of 2019 Full Year Results

IRVINE, CA, and HERSTAL, BELGIUM – January 10, 2020 – MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular diagnostics company, today announced that it will release its financial results for the full year ended 31 December 2019 on Wednesday 26 February 2020. Michael K. McGarrity, Chief Executive Officer and Ron Kalfus, Chief Financial Officer, will host a conference […]